Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Author Guidelines

Structure of article
The article should be clearly divided into sections. Each subsection should include a title in a separate line. Subsections should be used as often as possible so that the author could refer to subsections rather than whole article.
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Materials and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.
Results should be clear and concise. SI units should be used.
That section should extend, not repeat, the importance of the study results. It is often appropriate combine Results and Discussion. Extensive quotations and published literature analyses should be avoided in this section.
The main conclusions of the study may be presented in a this section. It may stand alone or form a subsection of a Discussion or Results sections.

Title page – necessary information
Title in English (up to 150 characters – including letters and spaces). Concise and informative. Titles are often used in databases and information-retrieval systems. Avoid abbreviations and formulae where possible.
A short title to be placed in the heading, not longer than 40 characters (including letters and spaces).
Author names and affiliations (authors’ full name(s) and family name(s) – first name, initial of the second name, family name). If the name is ambiguous (e.g. hyphenated name), please take due account. Authors’ full affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name. Provide the full name of the institution(s) or unit(s) where the work was done.
Corresponding author should be clearly indicated to handle correspondence at all stages of publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Data must be valid.
Valid/permanent address If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.

A concise and factual abstract is required in  English (250 characters each) where the author states briefly the purpose of the research, principal results and major conclusions. An should be so designed that it can be presented separately. Avoid references, but if essential, then cite the author(s) and year(s). Non-standard or uncommon abbreviations can be used, but must be defined at their first mention.
For original articles only, it is necessary for the abstract to be divided into five sections:
Introduction, Aim, Materials and methods, Results, Conclusion
Data stated in the abstract must also occur in the text and tables.

Key words
Five keywords or short phrases in Polish and English should be placed at the bottom of the title page. It is suggested that terms according to Index Medicus (Medical Subject Headings) should be used. Key words may not be a repetition of the title
Each abbreviation, both English and Polish, should be defined at its first use, whether in the main text or abstract. Abbreviations should be consistent throughout the text. If there is a large number of terms, a separate glossary may be used.


Place acknowledgements at the end of the article before the references, in a separate section. Please, do not place them in the beginning of the text, on the title page. List those individuals who provided help during the research (e.g., providing help in access to data, proofreading, linguistic revision, etc.).

Electronic artwork
General points
Make sure you use uniform lettering and sizing of your original artwork.
Text should be saved as illustration or font enclosed
The only accepted fonts are: Arial, Courier, Times, Symbol.
Number the illustrations according to their sequence in the text – figures with Arabic numerals, tables with Roman numerals
References must be made in the text to particular illustrations and tables.
Provide a list of illustrations in a separate file.
Submit each illustration as a separate file.

Regardless of the application used, when your electronic artwork isfinalized, please 'Save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: vector drawings; embed all used fonts or save thefile as “graphics”.
TIFF: Colour or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF: Bitmapped line drawings, keep to a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (colour or grayscale), keep to a minimum of 500 dpi.
If the electronic version of the artwork is made in Microsoft Office (Word, PowerPoint, Excel), its format should not be changed.

Please do not:
Supply files in GIF, BMP, PICT, WPG formats as their resolution is low.
Supply files that are too low in resolution.
Submit graphics that are disproportionately large.
Figure captions
Ensure that each illustration has a caption. Supply captions in a separate file in Polish and English. A caption should comprise a brief title and a description of the illustration Keep text in the illustrations to a minimum but explain all symbols and abbreviations used.

The sequence of tables should be consistent with the sequence of the text. Place any table notes below the table body. Vertical rulers should be avoided. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article.

Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications
are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list, they should follow the standard reference style of the journal and should include the publication date. Citation of a reference as ‘in press press’ implies that the item has been accepted for publication.
Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles in the same Special Issue.
Reference style
Text: each reference should be marked in the text with an Arabic numeral in a square bracket (no superscript or subscript).
List: references should be arranged in the order of their occurrence in the text.
Up to six authors:
1. Lanita R, Kluger J, Drayer DE, Koffler D, Reidenberg MM. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. N Engl J Med 1979;301:1382-5.

More than six authors:
2. Parkin AE, Clay BC, Beta MR, Alfa T, Teta K, Roberts M, et al. Leukaemia problems in Europe. Ann Transplant 1991;24:1050-3.

Institution as an author:
3. The Cardiac Society of Australia and New Zealand. Clinical exercise stress testing. Safety and performance guidelines. Med. J Aust 1996;164:282-4.

No authors:
4. Cancer in South Africa [editorial]. S Afr Med. J 1994;84:115

Books and monographs; one or more authors:
5. Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996
Editor(s) as an author:
6. Norman IJ, Redfern SJ, editors. Menthal health care for elderly people. New York: Churchill Livingstone; 1996.

For more information see ‘Uniform Requirements for Manuscripts submitted to Biomedical Journals’ (J Am Med Assoc 1997;277:927–34) (see also

Sources of journal abbreviations
Journal abbreviations should be consistent with the list in Index Medicus;
List of title word abbreviations:; CAS (Chemical Abstracts):

Privacy Statement


Dear Sir/Madam,
pursuant to Article 13 of Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data and repealing Directive 95/46/EC (General Data Protection Regulation), hereinafter referred to as GDPR, I inform you that:
1. The administrator of your personal data shall be the Maria Sklodowska-Curie Greater Poland Cancer Centre based in Poznan (61-866), Garbary St. 15, an independent public healthcare centre.
2. For all matters relating to the processing and protection of your personal data, you can contact the Data Protection Inspector via e-mail or by post to the following address: Garbary 15 St., Poznan (61-866), with the annotation Data Protection Inspector.
3. Your personal data are required in order to register on
4. Your personal data include: first name, last name, e-mail address, username, affiliation, country of origin.
5. Your personal data will be processed on the basis of Article 6(1)(a) (expressed consent) by indicating your consent to data processing during registration.
6. If the Greater Poland Cancer Centre collects personal data directly from you, I would like to inform you that the provision of this data is voluntary, however it is a prerequisite for registration on
7. You have the right of access to the content of your data, the right to rectification, the right to object, the right to limited processing, the right to data portability to another administrator and the right to erasure, or, if the processing is based on consent, the right to withdraw it at any time without affecting the lawfulness of the processing carried out on the basis of consent before its withdrawal. If you wish to exercise the above-mentioned rights, please send an e-mail to
8. You also have the right to file a complaint with the Supervisory Authority, which is the President of the Data Protection Authority, if you consider that the processing of personal data concerning you violates the provisions of the GDPR.
9. The Greater Poland Cancer Centre, as the Administrator, is committed to the confidentiality of your personal data. However, due to the necessity to fulfil the purpose of processing, legal obligations imposed on the Greater Poland Cancer Centre, or the necessity to ensure appropriate work organisation, e.g. in terms of IT

infrastructure, security of processed data, your personal data may be disclosed to entities with whom the Greater Poland Cancer Centre has concluded separate agreements for the provision of services entities supplying the Administrator with technical and IT and organisational solutions, to controlling entities or other entities authorised by law.
10. Your data are not subject to automated decision-making, including profiling.
11. Your personal data will not be transferred to a third country/international organisation, i.e. outside the European Economic Area.
12. Your personal data will be kept until the time necessary to fulfil the purpose referred to in pt 3, including the right to withdraw consent, archiving deadlines and the assertion of potential claims.